GSR: Glutathione reductase, mitochondrial
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Catalyzes the reduction of glutathione disulfide (GSSG) to reduced glutathione (GSH).
- Drugs that act on it: 2
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Carmustine | Approved | Glutathione reductase inhibitor | Inhibitor | — |
| Oxiglutatione | — | Glutathione reductase other | Other | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Hemolytic anemia due to glutathione reductase deficiency
- 0.70
- Glioblastoma
- 0.56
- Plasma cell myeloma
- 0.54
- Hodgkins lymphoma
- 0.53
- Neurodegenerative disease
- 0.49
- Glioma
- 0.47
- Medulloblastoma
- 0.46
- Malignant glioma
- 0.45
- Neoplasm
- 0.40
Drugs and mechanisms are from ChEMBL CHEMBL2755 (CC BY-SA 3.0). Gene name, function (UniProt P00390, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets